December 17, 2020
Decision Diagnostics Corp.'s chief executive went on a publicity spree boasting that the biotechnology company could accurately test for COVID-19 with a finger-prick of blood and provide near-instant results, but it wasn't true, the U.S. Securities and Exchange Commission said in a Manhattan federal lawsuit Thursday.